Cost-effectiveness of treatment strategies for intermittent claudication: A Multicenter Randomized Controlled Trial.

Recruiting

• Conditions: Peripheral Arterial Disease, Intermittent claudication, Endovascular revascularization, Supervised exercise

• Registration Number: NL-OMON29241

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 210

Inclusion Criteria

1. Rutherford category 1, 2, or 3 (> 3 months duration);

2. ABI <0.9 at rest or ABI decreasing by >0.15 after treadmill test;

Exclusion Criteria

1. Lesions deemed unsuitable for revascularization;

2. Abdominal aortic aneurysm >5 cm or iliac aneurysm >1.5 cm;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maximum walking distance.

Secondary Outcome Measures

Name	Time	Method
1. Preference based utilities (EQ-5D and Rating Scale);<br /><br>2. Health status QoL scores (SF-36 and VascuQol);<br /><br>3. ABI;<br /><br>4. Maximum painless walking distance;<br /><br>5. Clinical success;<br /><br>6. Therapeutic and total costs;<br /><br>7. CVD risk factor score; <br /><br>8. Number of events.